Ana M. Bajo

Has grant

Country flagSpain

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Analysis of exosomes as biomarkers and therapeutic agents in prostate cancer.

Open Date: 2022-12-01

Close Date: 2023-11-01

Grant: Close

Characterization of new biomarkers for prostate cancer and their application in the early and non-invasive diagnosis of prostate diseases.

Open Date: 2021-01-01

Close Date: 2022-01-01

Grant: Close

Evaluation of the diagnostic and prognostic accuracy and the clinical utility of microRNAs in urine as a biomarker in prostate cancer

Open Date: 2020-01-01

Close Date: 2022-01-01

Grant: Close

Exosomal and non-exosomal microRNAs as biomarkers in the diagnosis and prognosis of prostate cancer. Preclinical efficacy of new metallodendrimers in the progression of PCa

Open Date: 2019-01-01

Close Date: 2022-12-01

Grant: Close

Exosomes as biomarkers in the diagnosis of Prostate Cancer. Preclinical efficacy of new metallodendrimers in the progression of CaP

Open Date: 2018-01-01

Close Date: 2020-01-01

Articles (3)

Prostate cancer (PCa) is the second most frequent and sixth most fatal cancer in men worldwide. Despite its high prevalence, our understanding of its etiology and the molecular mechanisms involved in the progression of the disease is substantially limited. In recent years, the potential participation of exosomes in this process has been suggested. Therefore, we aim to study the effect of exosomes isolated from the serum of patients with PCa on various cellular processes associated with increased tumor aggressiveness in two PCa cell lines: LNCaP‐FGC and PC3. The exosomes were isolated by filtration wand ultracentrifugation. Their presence was confirmed by immunodetection of specific markers and their size distribution was analyzed by Dynamic Light Scattering (DLS). The results obtained demonstrated that serum exosomes from PCa patients increased migration of PC3 cells and neuroendocrine differentiation of LNCaP‐FGC cells regardless of the grade of the tumor. PCa serum exosomes also enhanced the secretion of enzymes related to invasiveness and resistance to chemotherapeutics, such as extracellular matrix metalloproteases 2 and 9, and gamma‐glutamyltransferase in both cell lines. Altogether, these findings support the pivotal participation of exosomes released by tumoral cells in the progression of PCa. Future studies on the molecular mechanisms involved in the observed changes could provide crucial information on this disease and help in the discovery of new therapeutic targets.

Year:

2023

Year:

2022

Year:

2020

Collaborators (1)

Andrew Schally

University of Miami Miller School of Medicine

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.